ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2.

Brent N Rexer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.